Darwin
Europe, Salzburg, Austria, Salzburg
Description
Darwin develops technologies in house to solve scientifically and technically challenging issues.
Investor Profile
Darwin has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B rounds (top funding stages).
- Majority of deals are located in Slovenia.
- Strong thematic focus on Biotechnology.
Stage Focus
- Series B (100%)
Country Focus
- Slovenia (100%)
 scale(.12937)'%3e %3csvg width='12' viewBox='-120 -190.223125 240 309.188274' height='15.459'%3e %3cpath d='m110.26-19.478l9.74-143.75a280.22 280.22 0 0 0 -240 0l9.74 143.75a155.61 155.61 0 0 0 110.26 138.45 155.61 155.61 0 0 0 110.26 -138.45' fill='%23005da4'/%3e %3cpath d='m-90 0a138.29 138.29 0 0 0 90 100.77 138.29 138.29 0 0 0 90 -100.77l-45-60-18 24-27-54-27 54-18-24-45 60' fill='%23fff'/%3e %3cg id='wave' fill='%23005da4' transform='scale(5) translate(0 5.1962)'%3e %3cpath d='m-17.196-2.1962a6 6 0 0 0 8.1962 2.1962 6 6 0 0 1 6 0 6 6 0 0 0 6 0 6 6 0 0 1 6 0 6 6 0 0 0 8.1962 -2.1962v1.732a6 6 0 0 1 -8.1962 2.1962 6 6 0 0 0 -6 0 6 6 0 0 1 -6 0 6 6 0 0 0 -6 0 6 6 0 0 1 -8.1962 -2.1962z'/%3e %3c/g%3e %3cuse xlink:href='%23wave' transform='translate(0 17.321)'/%3e %3cg id='s' transform='translate(0,-120) scale(2.25)'%3e %3cpath stroke-width='.2' d='m0-5l1 3.2679 3.3301-0.7679-2.3301 2.5 2.3301 2.5-3.3301-0.7679-1 3.2679-1-3.2679-3.3301 0.7679 2.3301-2.5-2.3301-2.5 3.3301 0.7679z' fill='%23fd0'/%3e %3c/g%3e %3cuse xlink:href='%23s' transform='translate(-33.75,-45)'/%3e %3cuse xlink:href='%23s' transform='translate(33.75,-45)'/%3e %3cpath d='m-111.58-167.05l9.96 146.99a146.95 146.95 0 0 0 101.62 129.95 146.95 146.95 0 0 0 101.62 -129.95l9.96-146.99a280.22 280.22 0 0 0 8.42 3.82l-9.74 143.75a155.61 155.61 0 0 1 -110.26 138.45 155.61 155.61 0 0 1 -110.26 -138.45l-9.74-143.75a280.22 280.22 0 0 0 8.42 -3.82' fill='%23ed1c24'/%3e %3c/svg%3e %3c/g%3e %3c/svg%3e)
Industry Focus
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
